ATR pathway inhibition is synthetically lethal in cancer cells with ercc1 deficiency

Kareem N. Mohni, Gina M. Kavanaugh, David Cortez

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint Dive into the research topics of 'ATR pathway inhibition is synthetically lethal in cancer cells with ercc1 deficiency'. Together they form a unique fingerprint.

Medicine & Life Sciences